RLAY
RLAY
US75943R1023
Relay Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 15.355.000 10.007.000
53.4%
Cost of Revenue -- --
--
Gross Profit -- --
--
318.093.000 395.681.000
19.6%
Operating Income -302.738.000 -385.674.000
21.5%
Pretax Income -276.479.000 -337.708.000
18.1%
Net Income Common Stockholders -276.479.000 -337.708.000
18.1%
-- --
--
-- --
--
ende